Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology II > Adrenergic blocking agents: Lect 8 > Flashcards

Adrenergic blocking agents: Lect 8 Flashcards

1
Q

what is the short term effect of beta blockers on blood pressure

A
  • negative inotropic and chronotropic effect which slows the heart and decreases contractility
  • relaxation of skeletal muscle vasculature: B2 receptor blocked
    • decreased CO increases sympathetic input -> an initial rise in peripheral resistance due to blockade of β2 receptors in blood vessels, allowing the effect of α receptors to become dominant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the long term effect of beta blockers on blood pressure

A

There may be an initial rise in peripheral resistance due to blockade of β2 receptors in blood vessels, allowing the effect of α receptors to become dominant. Over time, however, peripheral resistance returns to normal and blood pressure goes down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Effects of beta blockers on respiration

A
  • causes Bronchoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta blockers will inhibit the vasodilation caused by β2 receptors, increasing the pressor effect of epinephrine. They should never be given to someone with pheochromocytoma without administering what drugs

A

concomminant administration of an alpha blocker!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why should beta-blockers not be given in people who have asthma/COPD

A

Beta-blockers causes bronchoconstriction and can be fatal!

  • beta1 selective drug might be tolerated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

function of beta-blockers in the eye

A
  • lowers intraocular pressure
    • decreases formation of aqueous humor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why should beta blockers be used with great caution in insulin dependent Type I diabetics

A
  • Glycogenolysis mobilizes glucose in response to hypoglycemia. This effect is decreased by β antagonists
    • In normal patients, when glycogenolysis and gluconeogenesis are inhibited, release of glucagon in response to hypoglycemia acts to increase the blood glucose
  • in type I diabetics, the glucagon response becomes impaired, and inhibition of glycogenolysis and decreased release of glucose from the liver due to beta blockade may impair the ability of diabetics to recover from hypoglycemia
  • Furthermore, beta antagonists will mask the normal symptoms of hypoglycemia, such as tremor and shakiness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Beta blockers have what effect on lipolysis, VLDL, and HDL?

A
  • inhibts lipolysis in fat cells (beta 3)
  • increases VLDL and decreases HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta blockers with local anesthetic activity (acebutolol, labetalol, metoprolol, pindolol, propranolol) should not be used in the eye because

A
  • they will anesthetize the cornea
  • corneal damage/scratching can occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA of propranolol

A
  • competitive antagonist at B1 and B2 receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Propranolol has what CV effects

A
  • Slows heart rate and decreases force of contraction
  • Slows conduction through the A-V node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Propranolol has what effect on renin and glycogenolysis

A
  • decreases renin (B1)
  • decreases glycogenolysis (B2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What beta blockers can be used as a local anesthetic

A
  • acebutolol
  • labetalol
  • metoprolol
  • pindolol
  • propranolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmacokinetics of Propranolol

  • route of administration
  • can it enter CNS?
  • where is it metabolized
A
  • oral
  • lipid soluble, enters CNS -> sedation
  • metabolized in the liver, cytochrome P450
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical uses of propranolol

A
  • treats HTN: not first line agent
  • decreases mortality following MI
  • improves symptoms of angina: decreases O2 demand
  • treat arrhythymias
  • improve long-term survival in stable congestive heart failure
  • Useful to slow heart and decrease blood pressure in hyperthyroidism
  • prevent migraine
  • decrease sympathetic symptoms of stage fright
  • Decreases catecholamine-induced tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Main side effect of beta blockers

A
  • Bronchoconstriction
    • do not use in asthmatics or COPD
  • Bradycardia
  • abrupt discontinuation -> arrhythmias
  • exercerbate unstable heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why should a person not take Cimetidine (Antacid and Antihistamine) and Propranol together

A
  • Cimetidine inhibits cytochrome P450 and will increase effects of propranolol -> bradycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA and clinical use of Timolol

A
  • non-selective beta blocker
  • used in eye to treat glaucoma
    • caution in asthma
19
Q

What are the three beta 1 selective blockade drugs that have effects primarily on the heart

A
  • Metroprolol
  • Atenolol
  • Bisoprolol
20
Q

Metroprolol, Atenolol, and Bisoprolol have what effects on the heart? clinical uses?

A
  • decrease HR and contractility
  • decrease oxygen consumption and demand
  • decrease renin release -> decrease blood pressure
    • used for treatment of HTN, increase life expectancy after MI, and migraine proplylaxis
21
Q

Why does taking selective beta 1 blocking agents give a better exercise tolerance?

A
  • There is no block of B2 effect on blood vessels to skeletal muscle
22
Q

Why does taking selective beta 1 blocking agents better to use to diabetes ?

A
  • No block on B2 gives less of an effect on glycogenolysis
23
Q

MOA and clinical use of Betaxolol (Betoptic)

A
  • selective β1 blocker
  • used for treatment of glaucoma
    • It is thought to be less likely to cause bronchoconstriction when used in the eye than timolol.
24
Q

MOA of Nebivolol (Bystolic)

A
  • Beta 1 selective blocker that also produces vasodilation
    • produces vasodilation due to NO release
  • Most selective drug for β1 receptors currently available
25
Q

MOA and clinical use of Esmolol (Brevibloc)

A
  • VERY short acting beta 1 blocker
    • half-life 8 min
  • Must be injected intravenously
  • Used when very short β blockade is wanted, or in critically ill patients in whom it may be necessary to rapidly remove the β-blocker effect
26
Q

β- Antagonists with intrinsic sympathetic activity (ISA): what does this mean?

A
  • beta blockers that have partial agonist activity
    • stimulate receptors when sympathetic activity is low
    • reduce effects when (NE, epi) is high
  • may decrease risk of bronchoconstriction or bradycardia
27
Q

MOA of Pindolol (Visken), carteolol (Cartrol), and penbutolol (Levatol)

A

non-selective β blockers which have some intrinsic sympathomimetic activity (ISA)- that is, they are partial agonists

28
Q

MOA and clinical use of carteolol (Cartrol)

A
  • non-selective β blockers which have some intrinsic sympathomimetic activity (ISA)
  • used in eye to treat glaucoma
    • fewer systemic effects than timolol
29
Q

MOA of Acebutolol

A
  • selective β1 antagonist which has some intrinsic sympathomimetic activity (ISA)
30
Q

MOA of Labetalol and Carvedilol

A
  • Blocks β1 and β2 receptors, as well as α1 receptors​
  • α1 blockade leads to relaxation of arterial smooth muscle and decreased blood pressure
  • β1 blockade prevents a compensatory increase in heart rate, so that the decrease in blood pressure is less likely to cause tachycardia than when α-blockers are used alone
31
Q

clinical use of Labetalol

A
  • blocks B1, B2, and A1 receptors
  • Administered IV for the treatment of hypertensive emergencies
32
Q

clinical use of Carvedilol (Coreg)

A
  • blocks B1, B2, A1 receptors
  • used in CHF, post MI
33
Q

DOC in treatment of glaucoma

A
  • Prostaglanin analogues (Iatanoprost-Xalatan)
    • increases uveoscleral outflow and increase flow through trabecular meshwork
34
Q

What beta blockers are commonly used in the treatment of glaucoma

A
  • Timolol
    • non-selective blocker, placed in eye. May be absorbed and cause bronchoconstriction
  • Betaxolol
    • B1- selective blocker. Fewer side effects but also less effective
35
Q

What alpha 2 agonists are commonly used in the treatment of glaucoma? MOA?

A
  • Brimonidine and Apraclonidine
  • decrease production of aqueous humor
  • cause vasoconstriction
  • increase outflow directly by increasing prostaglandins
36
Q

MOA of carbonic anhydrase inhibitor in the treatment of glaucoma

A
  • decrease production of intraocular fluid
37
Q

What drug class is used primarily in narrow angle glaucoma

A
  • cholinergic agonists: pilocarpine
    • affect vision**
38
Q

MOA of Guanethidine (Ismelin)

A
  • inhibits NE release from nerve terminals
    • needs to enter presynaptic terminal: cocaine will prevent effect
  • loss of sympathetic tone occurs with time
39
Q

side effects of Guanethidine (Ismelin)

A
  • was once used in the treatment of severe hypertension. It is no longer used
  • it causes complete loss of sympathetic activity
    • postural hypotension
    • decreased blood flow to the brain and heart
    • problems with ejaculation in men
    • diarrhea
40
Q

MOA of Reserpine

A
  • Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals.
  • It will cause depletion of norepinephrine, dopamine and serotonin, both from the peripheral nerve terminals and in the brain
41
Q

side effects of Reserpine

A
  • Low doses decrease blood pressure, possibly as a result of central effects, similar to methyldopa
  • Side effects include severe diarrhea, depression, sedation, and Parkinson’s-like symptoms
  • **No longer used clinically
42
Q

MOA of Metyrosine

A
  • blocks tyrosine hydroxylase; rate limiting step in formation of L-DOPA from tyrosine
  • inhibits synthesis of dopamine, NE, and Epi
43
Q

clinical use of Metyrosine

A
  • treatment of pheochromocytoma if alpha blockers are not sufficient to control BP

Pharmacology II (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions